About
Cochlear is a global medical device company based in Sydney, Australia, specializing in implantable hearing solutions for individuals with hearing loss. Founded in 1981, Cochlear has established itself as a leader in the field, helping over 700,000 people regain their hearing through innovative technologies. The company is dedicated to empowering individuals to connect with others and live fulfilling lives. Cochlear designs and manufactures a range of implantable devices, including the Nucleus Cochlear Implant System, the Hybrid Electro-Acoustic Implant, and the Baha Bone Conduction Implant. These products cater to various types of hearing loss, providing effective solutions for both adults and children. The company also offers sound processors that enhance the performance of its implants, reflecting its commitment to continuous technological advancement. With approximately 50% of the global cochlear implant market, Cochlear supports a large community of users and connects them with hearing professionals to ensure optimal outcomes. Recognized for its innovation, Cochlear continues to lead the way in improving hearing solutions worldwide.
Technologies
Keywords
Company Information
-
Employees 5000
-
Founded 1981
-
Annual Revenue $1531828000
Location
North Ryde, New South Wales, Australia
